<<SR_PageTitle>>

1New Brunswick Regulation 2009-136 under the Public Health Act is amended by repealing the heading “Report by medical practitioner, nurse practitioner or nurse” preceding section 3.

2Section 3 of the Regulation is repealed.

3The heading “Report by person in charge of institution” preceding section 4 of the Regulation is repealed.

4Section 4 of the Regulation is repealed.

5The heading “Report by chief executive officer of a regional health authority” preceding section 5 of the Regulation is repealed.

6Section 5 of the Regulation is repealed.

7Section 6 of the Regulation is amended

(a) by repealing the portion preceding paragraph (a) and substituting the following:

6A report made under section 27, 28 or 29 of the Act shall contain the following information:

(b) in paragraph (b) by striking out “a communicable disease or has suffered a reportable event” and substituting “a notifiable disease or has suffered a notifiable event”;

8The Regulation is amended in the French version by repealing the heading “Moment et forme du signalement” preceding section 7 and substituting the following:

Présentation et forme du rapport

9Section 7 of the Regulation is repealed and the following is substituted:

7A report made under section 27, 28 or 29 of the Act shall be delivered as follows:

(a) for those notifiable diseases or notifiable events listed in Part 1 of Schedule A – orally within one hour after identification, followed by a written report by the end of the next working day;

(b) for those notifiable diseases or notifiable events listed in Part 2 of Schedule A – orally as soon as possible within 24 hours after identification, followed by a written report within one week; and

(c) for those notifiable diseases or notifiable events listed in Part 3 of Schedule A – in writing within one week after identification.

10Section 8 of the Regulation is repealed and the following is substituted:

8(1)A medical practitioner, nurse practitioner or nurse who carries out anonymous testing under a program authorized by the Minister is exempt from the requirement of making a report under section 27 of the Act with respect to persons who are tested for human immunodeficiency virus.

8(2)If anonymous testing is carried out by a regional health authority under a program authorized by the Minister, the chief executive officer of the regional health authority, or a person designated by the chief executive officer, is exempt from the requirement of making a report under section 30 of the Act with respect to persons who are tested for human immunodeficiency virus, but shall report the number of positive tests results determined as a result of the anonymous testing as soon as practicable.

11Section 9 of the Regulation is repealed and the following is substituted:

9(1)The following diseases are prescribed for the purposes of section 31 of the Act:

(a) a sexually transmitted disease;

(b) a notifiable disease listed in Part 1, Part 2 or Part 3 of Schedule A; and

(c) a notifiable event listed in Part 1, Part 2 or Part 3 of Schedule A.

9(2)A report made under section 31 of the Act shall contain the following information:

(a) the names of all known contacts of the person;

(b) the addresses of all known contacts; and

(c) the telephone numbers for all known contacts.

12The Regulation is amended in the French version by repealing the heading “Signalement des refus ou des négligences en matière de traitement” preceding section 10 and substituting the following:

Rapport concernant les refus ou les négligences en matière de traitement

13Section 10 of the Regulation is repealed and the following is substituted:

10(1)A report under section 32 of the Act shall be made orally to a medical officer of health without delay, followed by a written report within 24 hours after making the oral report.

10(2)A report made under section 32 of the Act shall contain the following information:

(a) the name and home address of the person;

(b) the Medicare number of the person;

(c) the telephone numbers for the person;

(d) the name of the Group I notifiable disease; and

(e) any relevant clinical information.

14Section 11 of the Regulation is amended by repealing the portion preceding paragraph (a) and substituting the following:

11A report under section 29 of the Act shall by made orally to a medical officer of health or a person designated by the Minister within 24 hours and shall contain the following information:

15Section 12 of the Regulation is repealed and the following is substituted:

12(1)For the purposes of subsection 42.1(1) of the Act, the following diseases are prescribed:

(a) diphtheria;

(b) tetanus;

(c) polio;

(d) pertussis;

(e) measles;

(f) mumps;

(g) rubella;

(h) varicella; and

(i) meningococcal disease.

12(2)For the purposes of subsection 42.1(2) of the Act, the following diseases are prescribed:

(a) diphtheria;

(b) tetanus;

(c) polio;

(d) pertussis;

(e) measles;

(f) mumps;

(g) rubella;

(h) varicella;

(i) meningococcal disease;

(j) Haemophilus influenzae type B disease; and

(k) pneumococcal infection.

16The heading “Communicable diseases prescribed” preceding section 16 of the Regulation is repealed.

17Section 16 of the Regulation is repealed.

18The heading “Group I communicable disease prescribed” preceding section 17 of the Regulation is amended by striking out “communicable disease” and substituting “notifiable diseases”.

19Section 17 of the Regulation is repealed and the following is substituted:

17The following diseases are prescribed as Group I notifiable diseases:

(a) human influenza caused by a new subtype;

(b) poliomyelitis due to wild-type poliovirus;

(c) severe acute respiratory syndrome; and

(d) smallpox.

20The heading “Reportable events prescribed” preceding section 18 of the Regulation is repealed and the following is substituted:

Notifiable events prescribed

21Section 18 of the English version of the Regulation is amended by striking out “reportable events” and substituting “notifiable events”.

22Schedule A of the Regulation is repealed and the attached Schedule A is substituted.

23This Regulation comes into force on February 1, 2018.

SCHEDULE A

The reporting requirements for those notifiable diseases and notifiable events as listed below are as follows:

Part 1: Orally within one hour after identification, followed by a written report by the end of the next working day.

Part 2: Orally as soon as possible within 24 hours after identification, followed by a written report within one week after identification.

Part 3: In writing within one week after identification.

Part 1	Part 2	Part 3
Notifiable Diseases
Anthrax	Brucellosis	Chlamydial infection (genital)
Botulism	Campylobacteriosis	Clostridium difficile associated diarrhea
Cholera	Cryptosporidiosis	Creutzfeld-Jacob disease (Classic and New Variant)
Diphtheria	Cyclosporiasis	Cytomegalovirus (congenital/neonatal)
Human influenza caused by a new subtype	Escherichia coli infection (verotoxigenic)	Gonococcal infection
Measles	Giardiasis	Hepatitis C
Meningococcal disease (invasive)	Guillain-Barré syndrome	Hepatitis G
Plague	Hantavirus pulmonary syndrome	Hepatitis (other viral)
Poliomyelitis due to wild-type poliovirus	Haemophilus influenzae infection – all serotypes (invasive)	Herpes (congenital / neonatal)
Severe acute respiratory syndrome	Hepatitis A	Human immunodeficiency virus infection / Acquired immunodeficiency syndrome
Smallpox	Hepatitis B	Influenza (laboratory confirmed)
Yellow fever	Hepatitis E	Leprosy
Viral Haemorrhagic fever	Legionellosis	Leptospirosis
	Listeriosis (invasive)	Lyme borreliosis
	Mumps	Malaria
	Paralytic shellfish poisoning	Methicillin-resistant Staphylococcus aureus
	Pertussis	Pneumococcal infection (invasive)
	Q fever	Psittaccosis
	Rabies	Rickettsial infection
	Rubella (including congenital)	Streptococcus group B infection (neonatal)
	Salmonellosis	Syphilis (including congenital)
	Shigellosis	Tetanus
	Staphylococcus aureus foodborne intoxications	Toxoplasmosis
	Streptococcus group A infection (invasive)	Vancomycin-resistant Enterococci
	Tularemia
	Tuberculosis (active)
	Typhoid
	Varicella
	Vibrio species pathogenic to humans (other than Cholera)
	West Nile virus infection
	Yersinosis
Notifiable Events
Unusual clusters of suspect notifiable disease cases or clusters of unknown aetiology	Exposure to suspected rabid animal	Adverse reaction to a vaccine or other immunizing agent
Clusters of illness thought to be food- or water-borne or enteric	Unusual illness, defined as follows: patient presenting with symptoms that do not fit any recognizable clinical picture; known aetiology but not expected to occur in New Brunswick; known aetiology that does not behave as expected or clusters presenting with unknown aetiology
Clusters of severe or atypical illness thought to be respiratory-borne

2018-7 - Public Health Act

Copy to Clipboard